Phosphorus

On World Osteoporosis Day, take five steps to better bone health

Retrieved on: 
Thursday, October 20, 2022

NYON, Switzerland, Oct. 20, 2022 /PRNewswire/ -- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention.

Key Points: 
  • NYON, Switzerland, Oct. 20, 2022 /PRNewswire/ -- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention.
  • IOF recommends a five step approach to better bone health and osteoporosis prevention.
  • Discuss bone health with your doctor and don't hesitate to ask for assessment and care if you are at risk.
  • World Osteoporosis Day, marked on October 20, calls for global action to fight osteoporosis and related fractures.

Casio to Release Flare Red Models for G-SHOCK 40th Anniversary Kickoff

Retrieved on: 
Thursday, October 20, 2022

TOKYO, Oct. 20, 2022 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the release of two new additions to the G-SHOCK brand of shock-resistant watches. In the runup to the G-SHOCK 40th anniversary in April 2023, Casio is looking to connect with each and every G-SHOCK fan through various activities, including releasing commemorative models and holding special events in various places around the world. Casio kicks this all off with the MTG-B3000FR and GWG-2040FR, two Flare Red anniversary models boasting the red G-SHOCK brand color in an intensely blazing solar flare design.

Key Points: 
  • In the runup to the G-SHOCK 40th anniversary in April 2023, Casio is looking to connect with each and every G-SHOCK fan through various activities, including releasing commemorative models and holding special events in various places around the world.
  • Casio kicks this all off with the MTG-B3000FR and GWG-2040FR, two Flare Red anniversary models boasting the red G-SHOCK brand color in an intensely blazing solar flare design.
  • The 40th anniversary Flare Red models, the MTG-B3000FR and GWG-2040FR, feature multicolor laminated bezels made with phosphorescent materials in the red G-SHOCK brand color.
  • The logo commemorating the G-SHOCK 40th anniversary, designed by world-renowned graffiti artist Eric Haze, is engraved on the case back.

Phosphoric Acid Global Market Report 2022: Usage in Fertilizer Production Bolsters Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 19, 2022

The phosphoric acid market was evaluated at US$44.404 billion for the year 2020, growing at a CAGR of 3.58%, reaching a market size of US$56.788 billion by the year 2027.

Key Points: 
  • The phosphoric acid market was evaluated at US$44.404 billion for the year 2020, growing at a CAGR of 3.58%, reaching a market size of US$56.788 billion by the year 2027.
  • Phosphoric acid is a type of inorganic acid that is primarily derived from phosphate rocks.
  • There are wide applications of phosphoric acid that include fertilizer production and as an additive in food and beverages, along with some uses in pharmaceutical applications.
  • This, in turn, acts as a catalyst for market growth as the majority of the phosphoric acid that is produced globally is used for manufacturing fertilizers.

GLOW® Beverages Inc. Debuts GLOW® Sparkling Hydration, GLOW® Sparkling Energy, and GLOW® Ultra Smooth Alkaline Water Product Lines with Nationwide Distribution

Retrieved on: 
Tuesday, October 18, 2022

LOS ANGELES, Oct. 18, 2022 /PRNewswire/ -- GLOW® Beverages Inc. is excited to announce the debut of their functional sparkling beverage line which includes hydration and energy. The immune-forward brand is launching with six flavor skus: Spicy Watermelon, Mango Apricot, Ginger Lemon, Cherry Lime, Pineapple Blood Orange and Tiger's Blood. They will also carry GLOW® PH, an Ultra Smooth Alkaline Water. 

Key Points: 
  • The product line also has GLOW PH, an Ultra Smooth Alkaline Water with 150+ TDS.
  • The low-calorie treat was invented when founders Kev Kouyoumjian and John Larson noticed a whitespace in the functional beverage category.
  • Historically, sparkling waters have lacked function and functional beverages don't offer sparkling (carbonated) versions of their product.
  • The brand can also be found in Costco's in the Bay Areastarting October 18thwith the official launch of GLOW Ultra Smooth Alkaline water.

Global Solar Panel Market Report 2022: Market to Grow at a CAGR of 20.24% During 2021-2027 - Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, October 14, 2022

The "Solar Panel Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Solar Panel Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global solar panel market size reached 177.7 GW in 2021.
  • A solar panel, also known as a PV panel, is a collection of solar (or photovoltaic) cells that employ natural sunlight to generate electricity.
  • Key Questions Answered in This Report:
    How has the global solar panel market performed so far and how will it perform in the coming years?

Outlook on the Hydrazine Global Market to 2030 - Increasing Demand from End-use Industries Such as Polymers, Pesticides, Pharmaceuticals and Water Treatment is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 12, 2022

The global hydrazine market was valued at $510.95 million in 2020, and is projected to reach $806.09 million by 2030, growing at a CAGR of 4.71% from 2021 to 2030.

Key Points: 
  • The global hydrazine market was valued at $510.95 million in 2020, and is projected to reach $806.09 million by 2030, growing at a CAGR of 4.71% from 2021 to 2030.
  • The global hydrazine market is driven primarily by increasing demand from end-use industries such as polymers, pesticides, pharmaceuticals, and water treatments.
  • Health concerns are expected to impede growth of the hydrazine market and pose challenges for industry participants during the forecast period.
  • However, demand for hydrazine hydrate in pharmaceutical and water treatment segments are unlikely to be affected by the coronavirus crisis.

Amolyt Pharma Announces Positive Safety and Efficacy Results from Second Patient Cohort in its Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism

Retrieved on: 
Wednesday, October 12, 2022

LYON, France and CAMBRIDGE, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced positive results from the second patient cohort in its Phase 2a clinical proof of concept trial of AZP-3601, a PTH1 receptor agonist, which the company is developing as a potential treatment for hypoparathyroidism.

Key Points: 
  • Consistent with Cohort 1, mean albumin-adjusted serum calcium (AdsCa) remained within the target range.
  • 24-hour urinary excretion of calcium was rapidly normalized in all but one patient, including those with hypercalciuria at baseline.
  • Consistent with the findings in bone biomarkers, bone mineral density (BMD) was stable, including in patients with osteopenia.
  • In this second cohort, 16 patients with hypoparathyroidism received daily subcutaneous injections of AZP-3601 during a four-week main treatment period, followed by an eight-week extension phase.

Amolyt Pharma to Present Full Phase 2a Data on AZP-3601 at Upcoming Conferences

Retrieved on: 
Wednesday, October 12, 2022

At the 38th Congress of the French Society of Endocrinology, Professors Peter Kamenicky and Istvan Takacs will discuss clinical needs in hypoparathyroidism and the results of the AZP-3601 Phase 2a clinical trial in more detail.

Key Points: 
  • At the 38th Congress of the French Society of Endocrinology, Professors Peter Kamenicky and Istvan Takacs will discuss clinical needs in hypoparathyroidism and the results of the AZP-3601 Phase 2a clinical trial in more detail.
  • At the International HypoPARAthyroidism Conference, Amolyt Pharmas Chief Medical Officer Mark Sumeray, M.D., will discuss the differentiated mechanism of action of AZP-3601, a parathyroid hormone (PTH)-1 receptor agonist, designed for the treatment of hypoparathyroidism and data from Phase 2a trial.
  • Hypoparathyroidism is defined by a deficiency of parathyroid hormone (PTH) that results in decreased calcium and elevated phosphorus levels in the blood.
  • Approximately 80% of the estimated 80,000 people in the U.S. and 110,000 in the European Union with hypoparathyroidism are women.

Vitamin D Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 7, 2022

The "Vitamin D Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Vitamin D Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The vitamin D market research report is one of a series of new reports that provides vitamin D market statistics, including vitamin D industry global market size, regional shares, competitors with a vitamin D market share, detailed vitamin D market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin D industry.
  • The faster-acting vitamin D supplement is a key trend gaining popularity in the vitamin D market.
  • Faster-acting vitamin D supplements are nutrients that help to balance the optimal levels of vitamin D in the body more quickly than conventional vitamin D. These are innovative and effective vitamin D supplements used to treat patients with severe vitamin D deficiency faster and help them recover fast.

Phosphorus Launches New xIoT Remediation and Active Response Capabilities for Enhanced Enterprise Device Security

Retrieved on: 
Thursday, October 6, 2022

Our xIoT security platform already provides unmatched capabilities for finding, fixing, and monitoring xIoT devices.

Key Points: 
  • Our xIoT security platform already provides unmatched capabilities for finding, fixing, and monitoring xIoT devices.
  • The updated version of Phosphorus Enterprise xIoT Security Platform now includes new enhanced features across Configuration Management, Hardening, and Remediation.
  • For more information about Phosphorus, go to www.phosphorus.io or visit Phosphorus and its Mobile xIoT Security Lab at upcoming security conferences, including S4x23 and CircleCityCon.
  • Our Extended Enterprise xIoT Security Platform delivers Attack Surface Management, Hardening & Remediation, and Detection & Response to bring enterprise xIoT security to every cyber-physical Thing in your enterprise environment.